XNYSNVST
Market cap3.20bUSD
Jan 10, Last price
18.58USD
1D
-3.08%
1Q
2.48%
IPO
-33.64%
Name
Envista Holdings Corp
Chart & Performance
P/E
—
P/S
1.25
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
1.54%
Rev. gr., 5y
-2.04%
Revenues
2.57b
-0.10%
Net income
-100m
L
CFO
276m
+50.90%
Earnings
Feb 05, 2025
Profile
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 2,566,500 -0.10% | 2,569,100 2.40% | ||||||
Cost of revenue | 1,209,800 | 1,194,400 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 1,356,700 | 1,374,700 | ||||||
NOPBT Margin | 52.86% | 53.51% | ||||||
Operating Taxes | 45,300 | 45,900 | ||||||
Tax Rate | 3.34% | 3.34% | ||||||
NOPAT | 1,311,400 | 1,328,800 | ||||||
Net income | (100,200) -141.22% | 243,100 -7.74% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (7,900) | 12,700 | ||||||
BB yield | 0.20% | -0.21% | ||||||
| Debt | ||||||||
Debt current | 175,900 | 537,000 | ||||||
Long-term debt | 1,648,200 | 1,140,500 | ||||||
Deferred revenue | 8,400 | 8,600 | ||||||
Other long-term liabilities | 134,000 | 7,100 | ||||||
Net debt | 884,100 | 1,231,100 | ||||||
| Cash flow | ||||||||
Cash from operating activities | 275,700 | 182,700 | ||||||
CAPEX | (58,200) | (75,700) | ||||||
Cash from investing activities | (62,400) | (657,300) | ||||||
Cash from financing activities | 118,900 | 12,500 | ||||||
FCF | 1,181,400 | 1,177,600 | ||||||
| Balance | ||||||||
Cash | 940,000 | 606,900 | ||||||
Long term investments | (160,500) | |||||||
Excess cash | 811,675 | 317,945 | ||||||
Stockholders' equity | 415,700 | 507,900 | ||||||
Invested Capital | 5,584,500 | 5,391,655 | ||||||
ROIC | 23.90% | 24.50% | ||||||
ROCE | 22.61% | 23.52% | ||||||
| EV | ||||||||
Common stock shares outstanding | 166,900 | 177,600 | ||||||
Price | 24.06 -28.54% | 33.67 -25.28% | ||||||
Market cap | 4,015,614 -32.85% | 5,979,792 -25.28% | ||||||
EV | 4,899,714 | 7,210,892 | ||||||
EBITDA | 1,519,300 | 1,536,800 | ||||||
EV/EBITDA | 3.22 | 4.69 | ||||||
Interest | 63,400 | 38,400 | ||||||
Interest/NOPBT | 4.67% | 2.79% | ||||||